Dr. Kelly K. Hunt discusses findings that sentinel lymph node (SLN) biopsy when done after --rather than before--neoadjuvant chemotherapy cuts the need for axillary dissections in patients with stage T2-T3 breast tumors . Sherry Boschert of the Global Medical News Network (GMNN) reports from the annual meeting of the American Surgical Association in Indian Wells, Calif.